sarepta therapeutics inc
(SRPT:Consolidated Issue Listed on NASDAQ Global Select )
Patrick L. Iversen Ph.D.
Senior Vice President of Research & Innovation, Sarepta Therapeutics, Inc.
|Age||Total Calculated Compensation||This person is connected to 0 board members in 0 different organizations across 2 different industries.|
Dr. Patrick L. Iversen, Ph.D. has been Senior Vice President of Research and Innovation at AVI Biopharma, Inc. since October 2010. In this position, Dr. Iversen has expanded responsibility for the identification and advancement of new drug discovery initiatives and the development of novel therapeutic applications of AVI's RNA-based technology. Over the last 21 years, he has been a leading innovator in the research and development of RNA-based therapeutics. He has been ...
215 First StreetPhone: 857-242-3700
Cambridge, Massachusetts 02142
Board Members Memberships*
Senior Vice President of Research & Innovation
The University of Utah
Annual Compensation*There is no Annual Compensation data available.
Stock Options*There is no Stock Options data available.
Total Compensation*There is no Total Compensation data available.
|John C. Martin Ph.D.||Chairman and Chief Executive Officer|
Gilead Sciences Inc.
|William A. Carter M.D.||Chairman, Chief Executive Officer, President, Chief Scientific Officer, Chairman of Executive Committee, Member of Strategic Planning Committee and Member of Disclosure Controls Committee|
Hemispherx Biopharma, Inc.
|Robert L. Parkinson Jr.||Chairman, Chief Executive Officer and President|
Baxter International Inc.
|Friedhelm Blobel Ph.D.||Chief Executive Officer, President, Executive Director and Member of Business Development Committee|
SciClone Pharmaceuticals, Inc.
|Pascal Soriot||Chief Executive Officer, Executive Director and Member of Disclosure Committee|
|3.0M GBP||Compensation as of Fiscal Year 2013.|